个体化糖尿病技术的挑战与机遇:EASD与ADA糖尿病技术工作组立场声明
该立场声明由欧洲糖尿病研究协会(EASD)与美国糖尿病协会(ADA)糖尿病技术工作组发布,强调应根据个人需求、能力和偏好支持糖尿病患者使用合适的糖尿病技术,避免技术获取的不平等,并提出行动建议以促进技术广泛采用并缩小数字鸿沟。
要点
- 糖尿病技术从指尖血糖监测和机械胰岛素笔发展到自动化胰岛素输送系统,管理选择不断扩展。
- 技术获取不均衡且未普遍覆盖,不存在一刀切的方法,需个体化选择。
- 应通过教育和决心克服预设障碍,减少糖尿病技术提供中的差异和数字鸿沟。
核心结论
- 支持糖尿病患者根据个人需求、能力和偏好获取并使用合适的糖尿病技术,同时避免技术获取不平等。
研究设计与样本
- EASD与ADA糖尿病技术工作组发布的立场声明。
主要发现
- 糖尿病技术从1970年代的指尖血糖监测和机械胰岛素笔发展到现代自动化胰岛素输送系统,正在改变糖尿病管理选项。
- 技术获取既不统一也非普遍覆盖,没有一刀切的方法。
临床怎么用
- 医疗专业人员应支持个体化选择糖尿病技术,挑战预设障碍,通过教育促进技术可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
From fingerstick blood glucose monitoring and mechanical insulin pens in the 1970s to modern automated insulin delivery systems, rapidly progressing advances in diabetes technology are transforming management options for people with diabetes, particularly those with type 1 diabetes but also, increasingly, people with type 2 diabetes. However, access to life-changing diabetes technologies is neither uniform nor universally covered, and there is no one size fits all approach. In this position statement, we emphasise to healthcare professionals the importance of supporting individuals with diabetes to access and use the right diabetes technology according to personal needs, capabilities and preferences. In doing so, we highlight the equal importance of avoiding disparities in the provision of diabetes technology by challenging preconceived barriers, which can be overcome with education and determination. We also make a series of suggestions for action to advance the more widespread adoption of diabetes technology while minimising the 'digital divide'.
引用
- Bruttomesso D, Petrie JR, Evans M, et al. Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2026. PMID: 41820663. doi:10.1007/s00125-025-06651-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。